The study analysed records from almost 800,000 patients in order to assess the efficacy of MedAware’s algorithm.
Pluristem recently announced the postponement of a $30 million investment agreement with a Chinese investor.
The Israeli institute has already developed technology for predicting colon cancer among Maccabi Health Fund patients.
The suspected presence of the bacteria was discovered in laboratory tests carried out after the product was already on the shelves.
Israeli company OrCam has a discreet device that attaches to eyeglasses and reads aloud any text the wearer points to.
The US Federal Court of Appeals upheld a lower court's decision on cancer treatment Alimta.
Some analysts see distress signals in Teva's 2017 outlook, but most still recommend "Buy".
CEO Erez Vigodman retains the board's support even though the company's share has lost half its value.